TED-话题@MedSci

#TED#

72篇内容 | 2274人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1702916, encodeId=d2cc1e029162c, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=Lancet Oncol：Nintedanib+多西他赛二线治晚期NSCLC有效, objectType=article, longId=31711, objectId=182231e11f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=182231e11f0, replyNumber=0, likeNumber=71, createdTime=2014-03-15, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=182231e11f0, moduleTitle=Lancet Oncol：Nintedanib+多西他赛二线治晚期NSCLC有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=182231e11f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702919, encodeId=df061e02919b4, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=勃林格肺纤维化药物Nintedanib获FDA突破性治疗药物资格, objectType=article, longId=38021, objectId=0ab338021cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ab338021cd, replyNumber=0, likeNumber=113, createdTime=2015-04-19, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ab338021cd, moduleTitle=勃林格肺纤维化药物Nintedanib获FDA突破性治疗药物资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ab338021cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702917, encodeId=73ac1e029176e, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=NEJM：Nintedanib对特发性肺纤维化安全有效（INPULSIS试验）？, objectType=article, longId=36439, objectId=b4a0364396f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4a0364396f, replyNumber=0, likeNumber=69, createdTime=2015-04-12, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4a0364396f, moduleTitle=NEJM：Nintedanib对特发性肺纤维化安全有效（INPULSIS试验）？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4a0364396f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702920, encodeId=63e61e02920b5, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=FDA授予勃林格殷格翰激酶抑制剂nintedanib突破性疗法认定, objectType=article, longId=38055, objectId=fc3c38055d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc3c38055d3, replyNumber=0, likeNumber=77, createdTime=2014-10-05, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc3c38055d3, moduleTitle=FDA授予勃林格殷格翰激酶抑制剂nintedanib突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc3c38055d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702914, encodeId=48fa1e0291409, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=勃林格殷格翰向EMA提交nintedanib上市许可申请, objectType=article, longId=25501, objectId=394e2550182, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=394e2550182, replyNumber=0, likeNumber=76, createdTime=2013-12-14, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=394e2550182, moduleTitle=勃林格殷格翰向EMA提交nintedanib上市许可申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=394e2550182)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702913, encodeId=2d991e029132a, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=BI向EMA提交肺癌药物Nintedanib的上市许可申请, objectType=article, longId=25482, objectId=615d254828b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=615d254828b, replyNumber=0, likeNumber=57, createdTime=2014-02-27, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=615d254828b, moduleTitle=BI向EMA提交肺癌药物Nintedanib的上市许可申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=615d254828b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702915, encodeId=3d4b1e0291556, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=MedSci期刊选择智能支持系统(Journal selection-assisted system)升级成功, objectType=article, longId=30317, objectId=5a5f3031e9f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a5f3031e9f, replyNumber=0, likeNumber=85, createdTime=2014-10-15, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a5f3031e9f, moduleTitle=MedSci期刊选择智能支持系统(Journal selection-assisted system)升级成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a5f3031e9f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702911, encodeId=5f0d1e02911ed, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=安慰剂效应——Ted Kaptchuk找到了“假”药中的真成分, objectType=article, longId=19038, objectId=374b190383a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=374b190383a, replyNumber=0, likeNumber=76, createdTime=2014-01-28, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=374b190383a, moduleTitle=安慰剂效应——Ted Kaptchuk找到了“假”药中的真成分, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=374b190383a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702912, encodeId=d1751e0291294, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=ASCO 2013：一线治疗之Nintedanib对索拉非尼的头对头临床试验, objectType=article, longId=19772, objectId=3ba219e728b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ba219e728b, replyNumber=0, likeNumber=67, createdTime=2014-01-30, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ba219e728b, moduleTitle=ASCO 2013：一线治疗之Nintedanib对索拉非尼的头对头临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ba219e728b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702910, encodeId=326e1e02910c4, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=Clini Cancer Res：抵御卵巢癌的新型药物lurbinectedin（PM01183）, objectType=article, longId=12748, objectId=4b1c12e4853, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b1c12e4853, replyNumber=0, likeNumber=71, createdTime=2013-02-26, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b1c12e4853, moduleTitle=Clini Cancer Res：抵御卵巢癌的新型药物lurbinectedin（PM01183）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b1c12e4853)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702909, encodeId=5bba1e02909cb, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=什么是Nested case-control study（巢式病例对照研究）？, objectType=article, longId=9310, objectId=0aaf9310d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0aaf9310d9, replyNumber=0, likeNumber=84, createdTime=2013-01-10, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0aaf9310d9, moduleTitle=什么是Nested case-control study（巢式病例对照研究）？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0aaf9310d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702908, encodeId=67b91e029086e, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=BMJ：糖尿病问诊技巧培训未能改善1型糖尿病儿童血糖控制（DEPICTED研究）, objectType=article, longId=5980, objectId=c6ca598031, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6ca598031, replyNumber=0, likeNumber=84, createdTime=2013-02-09, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6ca598031, moduleTitle=BMJ：糖尿病问诊技巧培训未能改善1型糖尿病儿童血糖控制（DEPICTED研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6ca598031)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702907, encodeId=aa271e02907fe, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=POMR (Problem-Oriented Medical Records)表格式住院病历, objectType=article, longId=342, objectId=c838342ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c838342ee, replyNumber=0, likeNumber=62, createdTime=2011-06-09, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c838342ee, moduleTitle=POMR (Problem-Oriented Medical Records)表格式住院病历, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c838342ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

TED

2020-05-29

aliceclz (审核中...)

前往app查看评论内容

#TED#

Lancet Oncol：Nintedanib+多西他赛二线治晚期NSCLC有效

2014-03-15

aliceclz (审核中...)

前往app查看评论内容

#TED#

勃林格肺纤维化药物Nintedanib获FDA突破性治疗药物资格

2015-04-19

aliceclz (审核中...)

前往app查看评论内容

#TED#

NEJM：Nintedanib对特发性肺纤维化安全有效（INPULSIS试验）？

2015-04-12

aliceclz (审核中...)

前往app查看评论内容

#TED#

FDA授予勃林格殷格翰激酶抑制剂nintedanib突破性疗法认定

2014-10-05

aliceclz (审核中...)

前往app查看评论内容

#TED#

勃林格殷格翰向EMA提交nintedanib上市许可申请

2013-12-14

aliceclz (审核中...)

前往app查看评论内容

#TED#

BI向EMA提交肺癌药物Nintedanib的上市许可申请

2014-02-27

aliceclz (审核中...)

前往app查看评论内容

#TED#

MedSci期刊选择智能支持系统(Journal selection-assisted system)升级成功

2014-10-15

aliceclz (审核中...)

前往app查看评论内容

#TED#

安慰剂效应——Ted Kaptchuk找到了“假”药中的真成分

2014-01-28

aliceclz (审核中...)

前往app查看评论内容

#TED#

ASCO 2013：一线治疗之Nintedanib对索拉非尼的头对头临床试验

2014-01-30

aliceclz (审核中...)

前往app查看评论内容

#TED#

Clini Cancer Res：抵御卵巢癌的新型药物lurbinectedin（PM01183）

2013-02-26

aliceclz (审核中...)

前往app查看评论内容

#TED#

什么是Nested case-control study（巢式病例对照研究）？

2013-01-10

aliceclz (审核中...)

前往app查看评论内容

#TED#

BMJ：糖尿病问诊技巧培训未能改善1型糖尿病儿童血糖控制（DEPICTED研究）

2013-02-09

aliceclz (审核中...)

前往app查看评论内容

#TED#

POMR (Problem-Oriented Medical Records)表格式住院病历

2011-06-09

科室
- - 订阅+
  - 更多科室
工具
服务